Peter Ansell,Lei He,Xin Huang,Vasudha Sehgal,Bruce Bach
申请号：
US16626769
公开号：
US20200129482A1
申请日:
2018.06.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides methods of treating non-small cell lung cancer in a patient comprising administering to the patient an effective amount of a PARP inhibitor, wherein the patient is Lung Subtyping Panel (LSP) positive.
